ClinicalTrials.gg
Not yet recruitingNCT07891026IAP-AKIUpdated Oct 23, 2026

Cumulative Intra-Abdominal Pressure Burden and Acute Kidney Injury After Emergency Abdominal Surgery

An observational study in Acute Kidney Injury and Intra-Abdominal Hypertension, sponsored by Ugur Duman. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Ugur Duman · Observational

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn whether increased pressure inside the abdomen over time is associated with acute kidney injury in adults receiving intensive care after emergency abdominal surgery. The main question it aims to answer is:

  • Is greater cumulative exposure to increased abdominal pressure associated with a higher risk of acute kidney injury? Participants will have abdominal pressure measured through a urinary catheter during routine intensive care. Researchers will record these measurements and information about kidney function without changing participants' treatment.
Read the detailed description

Intra-abdominal pressure varies during postoperative critical illness. Individual measurements and peak values may not fully characterize sustained or recurrent pressure elevation. Evaluating cumulative exposure may provide additional information about the relationship between abdominal pressure and postoperative renal dysfunction.

This single-center prospective observational cohort study will examine serial intra-abdominal pressure measurements obtained in a surgical intensive care unit after emergency abdominal surgery. Pressure will be measured using a standardized intravesical technique. Cumulative intra-abdominal pressure burden will be derived from repeated measurements, incorporating both the magnitude and duration of pressure elevation.

Mean arterial pressure will be recorded alongside intra-abdominal pressure to characterize the accompanying hemodynamic conditions. Abdominal perfusion pressure will be calculated as mean arterial pressure minus intra-abdominal pressure. These measurements will allow abdominal pressure exposure to be evaluated in the context of systemic pressure and abdominal perfusion.

Clinical data will include baseline renal function, illness severity, operative characteristics, fluid balance, and vasopressor use. Multivariable analyses will assess the association between cumulative pressure burden and acute kidney injury while accounting for relevant clinical factors. The predictive performance of cumulative exposure measures will also be compared with that of individual pressure measurements.

The study is observational. Clinical management will follow established practice, and treatment decisions will remain the responsibility of the attending clinicians.

02

Conditions studied

  • Acute Kidney Injury
  • Intra-Abdominal Hypertension

Keywords

  • Intra-Abdominal Pressure
  • Cumulative Intra-Abdominal Pressure Burden
  • Acute Kidney Injury
  • Abdominal Perfusion Pressure
  • Mean Arterial Pressure
  • Emergency Abdominal Surgery
  • Intensive Care Unit
  • KDIGO
  • Prospective Cohort Study
03

In context

Acute Kidney Injury

1,641 studies on the registry are indexed under Acute Kidney Injury; 380 are open to participants now.

This study's planned enrollment of 300 is above the median of 156 across 795 observational studies indexed under Acute Kidney Injury.

Browse Acute Kidney Injury studies →

Lead sponsor

Ugur Duman is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adult patients aged 18 years or older admitted to the general surgery intensive care unit following emergency abdominal surgery at Bursa Yuksek Ihtisas Training and Research Hospital, Turkiye. Patients with pre-existing acute kidney injury or acute kidney injury at postoperative ICU admission will be excluded. Eligible patients will be prospectively enrolled and monitored for the development of new-onset acute kidney injury within seven days after surgery. Serial intra-abdominal pressure measurements, hemodynamic parameters, renal function indicators, and clinical outcomes will be recorded.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Undergoing emergency abdominal surgery (open or laparoscopic).
  • Postoperative admission to the intensive care unit.
  • No evidence of acute kidney injury at postoperative ICU admission according to KDIGO criteria.
  • Availability of a urinary catheter for serial intravesical intra-abdominal pressure measurements.
  • Written informed consent obtained from the participant or a legally authorized representative, as applicable.

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years.
  • Pre-existing acute kidney injury before surgery or at postoperative ICU admission.
  • End-stage kidney disease requiring maintenance dialysis.
  • Conditions preventing reliable intravesical intra-abdominal pressure measurement, including major bladder injury.
  • Inability to obtain informed consent from the participant or a legally authorized representative, when required.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Emergency Abdominal Surgery ICU Cohort

    Adult patients admitted to the intensive care unit following emergency abdominal surgery, including open and laparoscopic procedures, will be prospectively enrolled in a single observational cohort. During the first 48 postoperative hours, intra-abdominal pressure will be measured serially using the intravesical pressure measurement technique. Mean arterial pressure will be recorded simultaneously, and abdominal perfusion pressure will be calculated as MAP minus IAP. Cumulative pressure burden parameters will be evaluated for their association with acute kidney injury occurring within the first seven postoperative days, according to KDIGO criteria. All patients will receive standard clinical care without any study-directed therapeutic intervention.

    Other: Serial Intra-Abdominal Pressure Measurement

Interventions

  • OtherSerial Intra-Abdominal Pressure Measurement

    Intra-abdominal pressure will be measured serially during the first 48 postoperative hours using the intravesical pressure measurement technique through a urinary catheter. Mean arterial pressure will be recorded simultaneously, and abdominal perfusion pressure will be calculated as MAP minus IAP. Cumulative IAP, APP, and MAP burden parameters will be derived from serial measurements. These assessments will be observational and will not influence clinical treatment decisions.

06

What researchers measure

Primary outcomes

  1. Incidence of Acute Kidney Injury Within Seven Postoperative Days

    The proportion of participants who develop acute kidney injury (AKI) within seven days following emergency abdominal surgery. AKI will be defined and staged according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria using changes in serum creatinine concentrations and urine output.

    Time frame: From surgery completion (day 0) through postoperative day 7

Secondary outcomes

  1. Incidence of KDIGO Stage 2 or 3 Acute Kidney Injury

    The proportion of participants who develop moderate to severe acute kidney injury, defined as KDIGO stage 2 or stage 3, based on serum creatinine changes and urine output criteria.

    Time frame: From surgery completion (day 0) through postoperative day 7

  2. Incidence of Oliguria

    The proportion of participants who develop oliguria during postoperative monitoring. Urine output will be assessed using hourly urine output measurements and evaluated according to KDIGO urine output criteria.

    Time frame: From surgery completion (day 0) through postoperative day 7

  3. Requirement for Renal Replacement Therapy

    The proportion of participants requiring renal replacement therapy during the postoperative intensive care period, including continuous or intermittent renal replacement modalities.

    Time frame: From postoperative intensive care unit admission (day 0) until intensive care unit discharge or death, whichever occurs first, assessed up to 28 days

  4. Intensive Care Unit Mortality

    The proportion of participants who die from any cause during the postoperative intensive care unit stay.

    Time frame: From postoperative intensive care unit admission (day 0) until intensive care unit discharge or death, whichever occurs first, assessed up to 28 days

  5. Intensive Care Unit Length of Stay

    Duration of postoperative intensive care unit stay, measured in days from intensive care unit admission until discharge or death.

    Time frame: From postoperative intensive care unit admission (day 0) until intensive care unit discharge or death, whichever occurs first, assessed up to 28 days.

07

Study locations

1 site
  • Bursa Yuksek Ihtisas Training and Research Hospital
    Bursa, 16310, Turkey (Türkiye)
    • Ugur Duman, MD · Contact · ugur.duman@sbu.edu.tr · +905458177971
    • Ugur Duman, MD · Principal investigator
08

References and documents

Publications

  • Miao S, Yang M, Li W, Yan J. Elevated IAP in critically ill patients associated with increased AKI incidence: a cohort study from the MIMIC-IV database. Sci Rep. 2025 Mar 10;15(1):8245. doi: 10.1038/s41598-024-84831-0. PubMed 40064930 ↗
  • Liu J, Lin SH, Zhao YS, Luo RJ, Zhang ZT, Wang LY, Xie K, Fan J, Zhang M, Chai YS, Tang H, Xu F. Incidence and risk factors of acute kidney injury after abdominal surgery: a systematic review and meta-analysis. Ann Med. 2025 Dec;57(1):2547324. doi: 10.1080/07853890.2025.2547324. Epub 2025 Aug 17. PubMed 40819346 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891026
Lead sponsor
Ugur Duman
Responsible party
Ugur Duman (Assistant Professor of General Surgery, Bursa Yuksek Ihtisas Training and Research Hospital) — Sponsor-investigator
First posted
Oct 23, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Nov 30, 2027 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Oct 23, 2026

Study contacts

Ugur Duman, MD
Contact
ugur.duman@sbu.edu.tr
+905458177971
Ugur Duman, MD
principal investigator · Bursa Yuksek Ihtisas Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion